سعر موبيتيل 7.5 مجم 2024

Meloxicam 7.5 mg tablets, 10 tablets, Medical Union Pharmaceuticals (Mobitil).

• Relief of signs and symptoms of osteoarthritis and rheumatoid arthritis in adults; juvenile rheumatoid arthritis (pauciarticular/polyarticular) in patients weighing ≥60 kg.Population: Adults; JRA patients ≥60 kgDailyMed (U.S. National Library of Medicine)

• Most common (≥5% and greater than placebo) in adults: diarrhea, upper respiratory tract infections, dyspepsia, and influenza-like symptoms.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to meloxicam or any component of the product.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Contraindicated in the setting of coronary artery bypass graft (CABG) surgery.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: NSAIDs increase risk of serious cardiovascular thrombotic events including MI and stroke; risk may occur early and increase with duration of use.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Boxed warning: NSAIDs increase risk of serious GI adverse events including bleeding, ulceration and perforation of the stomach or intestines, which can be fatal.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Hepatotoxicity, hypertension, heart failure/edema, renal toxicity, anaphylaxis, serious skin reactions including SJS/TEN/DRESS, and hematologic toxicity may occur; monitor as clinically indicated.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Anticoagulants (e.g. warfarin), antiplatelets, SSRIs/SNRIsMajorConcomitant use increases bleeding risk; monitor for bleeding.DailyMed (U.S. National Library of Medicine)
• ACE inhibitors, ARBs, or beta-blockersModerateNSAIDs may diminish antihypertensive effect; in elderly/volume-depleted/renal impairment, risk of renal deterioration.DailyMed (U.S. National Library of Medicine)
• LithiumMajorNSAIDs may raise plasma lithium and reduce renal clearance; monitor for lithium toxicity.DailyMed (U.S. National Library of Medicine)

• NSAIDs including meloxicam can cause premature closure of the fetal ductus arteriosus and fetal renal dysfunction leading to oligohydramnios. Limit use between about 20 and 30 weeks; avoid at about 30 weeks and later.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• No human data on presence in human milk; consider developmental and health benefits of breastfeeding along with the mother's clinical need.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Meloxicam: Oxicam NSAID; inhibits prostaglandin biosynthesis via COX-1 and COX-2.